MTOR and its link to the picture of Dorian Gray - re-activation of mTOR promotes aging

Aging

Volumn 2, Issue 12, 2010, Pages 892-893

  Wesierska Gadek, Józefa ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; ETOPOSIDE; IMIDAZOLE DERIVATIVE; MAMMALIAN TARGET OF RAPAMYCIN; MTOR PROTEIN, HUMAN; NUTLIN 3; PIPERAZINE DERIVATIVE; PROTEIN KINASE INHIBITOR; PROTEIN P53; RAPAMYCIN; TP53 PROTEIN, HUMAN;

ANIMAL; CELL AGING; CELL CYCLE; CELL PROLIFERATION; CELL SHAPE; DNA DAMAGE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; METABOLISM; NOTE; SERUM; TIME; UPREGULATION;

ANIMALS; CELL AGING; CELL CYCLE; CELL PROLIFERATION; CELL SHAPE; DNA DAMAGE; DOXORUBICIN; ENZYME ACTIVATION; ETOPOSIDE; HUMANS; IMIDAZOLES; PIPERAZINES; PROTEIN KINASE INHIBITORS; SERUM; SIROLIMUS; TIME FACTORS; TOR SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 79952260219     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100240     Document Type: Note

References (13)

1. Bartkova J, Rezaei N, Liontos M. et al. Nature 2006; 444: 633-637.
2. Collado M, Blasco MA, & Serrano M. Cell 2007; 130: 223-233.
3. Campisi J. Cell 2005, 120: 1-10.
4. Halazonetis TD, Gorgoulis VG. & Bartek J. Science 2008; 319: 1352-1355.
5. Feng Z, Hu W, Rajagopal et al. Cell Cycle 2008; 7: 842-847.
6. Serrano M, Lin Aw, McCurrach ME et al. Cell 1997; 88. 593-602.
7. Fujita K, Mondal AM, Horikawa I, et al. Nat .Cell. Biol. 2009; 11: 1135-1142.
8. Dai CY, Furth EE, Mick R, et al. Gastroenterology 2000; 119: 929-942.
9. Vousden KH & Ryan KM. Nat. Rev. Cancer 2009; 9: 691-700.
10. Demidenko ZN, Korotchkina LG, Gudkov AV, and Blagosklonny MV. Proc. Natl. Acad. Sci. 2010, 107:9660-9664.
11. Korotchkina LG, Leontieva OV, Bukreeva EI, Demidenko ZN, Gudkov AV, and Blagosklonny MV. AGING 20102:344-351.
12. Matheu A, Maraver A, Klatt P, et al. Nature 2007; 448: 375-379.
13. Leontieva OV and Blagosklonny MV. Aging 2010; 2: this issue.